Friday, April 5, 2013

Molecular Therapy - Table of Contents alert Volume 21 Issue 4


TABLE OF CONTENTS

Volume 21, Issue 4 (April 2013)

In this issue
Editorial
In This Issue
Research Highlights
Commentaries
Reviews
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
FREE 91 page eBook: Key Advances in Medicine

An essential resource for anyone with an interest in medicine, 45 articles summarise the groundbreaking clinical studies of 2012 and highlight trends to watch out for in 2013.

Download FREE PDF now!
 

Editorial

Top

Moving Forward on Shifting Sands: Ethical Regulation of Gene Therapy Clinical Trials in the United Kingdom

Emma Morris, Martin Gore, Andrew Baker and Adrian J Thrasher

Mol Ther 2013 21: 715-716; 10.1038/mt.2013.43

Full Text

In This Issue

Top

In This Issue

Mol Ther 2013 21: 718; 10.1038/mt.2013.44

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2013 21: 719; 10.1038/mt.2013.45

Full Text

Commentaries

Top

A Crisper Look at Genome Editing: RNA-guided Genome Modification

Mara Damian and Matthew H Porteus

Mol Ther 2013 21: 720-722; 10.1038/mt.2013.46

Full Text

“Infectious” Optimism for Treatment of Hepatocellular Carcinoma

Kenneth K Tanabe and E Antonio Chiocca

Mol Ther 2013 21: 722-724; 10.1038/mt.2013.47

Full Text

Reviews

Top

Mechanistic, Technical, and Clinical Perspectives in Therapeutic Stimulation of Coronary Collateral Development by Angiogenic Growth Factors

Gabor M Rubanyi

Mol Ther 2013 21: 725-738; advance online publication, February 12, 2013; 10.1038/mt.2013.13

Abstract | Full Text

Baculovirus: an Insect-derived Vector for Diverse Gene Transfer Applications

Kari J Airenne, Yu-Chen Hu, Thomas A Kost, Richard H Smith, Robert M Kotin, Chikako Ono, Yoshiharu Matsuura, Shu Wang and Seppo Ylä-Herttuala

Mol Ther 2013 21: 739-749; advance online publication, February 26, 2013; 10.1038/mt.2012.286

Abstract | Full Text

Original Articles

Top

Microdystrophin Ameliorates Muscular Dystrophy in the Canine Model of Duchenne Muscular Dystrophy

Jin-Hong Shin, Xiufang Pan, Chady H Hakim, Hsiao T Yang, Yongping Yue, Keqing Zhang, Ronald L Terjung and Dongsheng Duan

Mol Ther 2013 21: 750-757; advance online publication, January 15, 2013; 10.1038/mt.2012.283

Abstract | Full Text

Insulin-like Growth Factor-binding Protein-7 (IGFBP7): A Promising Gene Therapeutic for Hepatocellular Carcinoma (HCC)

Dong Chen, Ayesha Siddiq, Luni Emdad, Devaraja Rajasekaran, Rachel Gredler, Xue-Ning Shen, Prasanna K Santhekadur, Jyoti Srivastava, Chadia L Robertson, Igor Dmitriev, Elena A Kashentseva, David T Curiel, Paul B Fisher and Devanand Sarkar

Mol Ther 2013 21: 758-766; advance online publication, January 15, 2013; 10.1038/mt.2012.282

Abstract | Full Text

SR-A and SREC-I Are Kupffer and Endothelial Cell Receptors for Helper-dependent Adenoviral Vectors

Pasquale Piccolo, Francesco Vetrini, Pratibha Mithbaokar, Nathan C Grove, Terry Bertin, Donna Palmer, Philip Ng and Nicola Brunetti-Pierri

Mol Ther 2013 21: 767-774; advance online publication, January 29, 2013; 10.1038/mt.2012.287

Abstract | Full Text

Proteomic and Functional Analyses of Protein–DNA Complexes During Gene Transfer

Melissa A Badding, John D Lapek, Alan E Friedman and David A Dean

Mol Ther 2013 21: 775-785; advance online publication, November 20, 2012; 10.1038/mt.2012.231

Abstract | Full Text

Generation of an HIV Resistant T-cell Line by Targeted “Stacking” of Restriction Factors

Richard A Voit, Moira A McMahon, Sara L Sawyer and Matthew H Porteus

Mol Ther 2013 21: 786-795; advance online publication, January 29, 2013; 10.1038/mt.2012.284

Abstract | Full Text

Differential Type I Interferon-dependent Transgene Silencing of Helper-dependent Adenoviral vs. Adeno-associated Viral Vectors In Vivo

Masataka Suzuki, Terry K Bertin, Geoffrey L Rogers, Racel G Cela, Irene Zolotukhin, Donna J Palmer, Philip Ng, Roland W Herzog and Brendan Lee

Mol Ther 2013 21: 796-805; advance online publication, January 15, 2013; 10.1038/mt.2012.277

Abstract | Full Text

Gene Therapy Researchers' Assessments Of Risks And Perceptions Of Risk Acceptability In Clinical Trials

Claire T. Deakin, Ian E. Alexander, Cliff A. Hooker and Ian H. Kerridge

Mol Ther 2013 21: 806-815; advance online publication, January 22, 2013; 10.1038/mt.2012.230

Abstract | Full Text

Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes

Gayong Shim, Hyun-woo Choi, Sangbin Lee, Junhyeok Choi, Yong Hee Yu, Da-Eui Park, Yongseok Choi, Chan-Wha Kim and Yu-Kyoung Oh

Mol Ther 2013 21: 816-824; advance online publication, February 5, 2013; 10.1038/mt.2013.10

Abstract | Full Text

Lentiviral Delivery of RNAi for In Vivo Lineage-Specific Modulation of Gene Expression in Mouse Lung Macrophages

Andrew A Wilson, Letty W Kwok, Emily L Porter, Julie G Payne, Gregory S McElroy, Sarah J Ohle, Sara R Greenhill, Matthew T Blahna, Kazuko Yamamoto, Jyh C Jean, Joseph P Mizgerd and Darrell N Kotton

Mol Ther 2013 21: 825-833; advance online publication, February 12, 2013; 10.1038/mt.2013.19

Abstract | Full Text

siRNA Targeting Hes5 Augments Hair Cell Regeneration in Aminoglycoside-damaged Mouse Utricle

Jae Yun Jung, Matt R. Avenarius, Swetlana Adamsky, Evgenia Alpert, Elena Feinstein and Yehoash Raphael

Mol Ther 2013 21: 834-841; advance online publication, February 26, 2013; 10.1038/mt.2013.18

Abstract | Full Text

Targeting and Killing of Metastatic Cells in the Transgenic Adenocarcinoma of Mouse Prostate Model With Vesicular Stomatitis Virus

Maryam Moussavi, Howard Tearle, Ladan Fazli, John C Bell, William Jia and Paul S Rennie

Mol Ther 2013 21: 842-848; advance online publication, January 22, 2013; 10.1038/mt.2012.285

Abstract | Full Text

DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety

Katrin Friedrich, Jan RH Hanauer, Steffen Prüfer, Robert C Münch, Iris Völker, Christodoulos Filippis, Christian Jost, Kay-Martin Hanschmann, Roberto Cattaneo, Kah-Whye Peng, Andreas Plückthun, Christian J Buchholz, Klaus Cichutek and Michael D Mühlebach

Mol Ther 2013 21: 849-859; advance online publication, February 5, 2013; 10.1038/mt.2013.16

Abstract | Full Text

The Use of Scaffold-free Cell Sheet Technique to Refine Mesenchymal Stromal Cell-based Therapy for Heart Failure

Takuya Narita, Yasunori Shintani, Chiho Ikebe, Masahiro Kaneko, Niall G Campbell, Steven R Coppen, Rakesh Uppal, Yoshiki Sawa, Kenta Yashiro and Ken Suzuki

Mol Ther 2013 21: 860-867; advance online publication, January 29, 2013; 10.1038/mt.2013.9

Abstract | Full Text

Busulfan Conditioning Enhances Engraftment of Hematopoietic Donor-derived Cells in the Brain Compared With Irradiation

Fiona L Wilkinson, Ana Sergijenko, Kia J Langford-Smith, Marcela Malinowska, Rob F Wynn and Brian W Bigger

Mol Ther 2013 21: 868-876; advance online publication, February 19, 2013; 10.1038/mt.2013.29

Abstract | Full Text

Generation and Preclinical Characterization of a Fc-optimized GITR-Ig Fusion Protein for Induction of NK Cell Reactivity Against Leukemia

Benjamin Joachim Schmiedel, Antje Werner, Julia Steinbacher, Tina Nuebling, Corina Buechele, Ludger Grosse-Hovest and Helmut Rainer Salih

Mol Ther 2013 21: 877-886; advance online publication, February 5, 2013; 10.1038/mt.2013.11

Abstract | Full Text

HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy

Byram W Bridle, Lan Chen, Chantal G Lemay, Jean-Simon Diallo, Jonathan Pol, Andrew Nguyen, Alfredo Capretta, Rongqiao He, Jonathan L Bramson, John C Bell, Brian D Lichty and Yonghong Wan

Mol Ther 2013 21: 887-894; advance online publication, January 8, 2013; 10.1038/mt.2012.265

Abstract | Full Text

Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in PatientsMTOpen

Katrin S. Reiners, Jörg Kessler, Maike Sauer, Achim Rothe, Hinrich P. Hansen, Uwe Reusch, Christian Hucke, Ulrike Köhl, Horst Dürkop, Andreas Engert and Elke Pogge von Strandmann

Mol Ther 2013 21: 895-903; advance online publication, March 5, 2013; 10.1038/mt.2013.14

Abstract | Full Text

Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity

Cor HJ Lamers, Stefan Sleijfer, Sabine van Steenbergen, Pascal van Elzakker, Brigitte van Krimpen, Corrien Groot, Arnold Vulto, Michael den Bakker, Egbert Oosterwijk, Reno Debets and Jan W Gratama

Mol Ther 2013 21: 904-912; advance online publication, February 19, 2013; 10.1038/mt.2013.17

Abstract | Full Text

Corrigendum

Top

The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice

Mol Ther 2013 21: 913; 10.1038/mt.2013.48

Full Text

Submit to Molecular Therapy
Molecular Therapy (MT) is dedicated to publishing important peer-reviewed research and cutting-edge reviews and promoting the sciences in genetics, medicine and biotechnology. 
Find out more about MT and the benefits of submitting to the journal.
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: